---
title: Who We Are
---

[Skip to content](https://ntxbio.com/who-we-are#main-content)

[![](https://ntxbio.com/hs-fs/hubfs/Picture1.png?width=1224&height=332&name=Picture1.png)](https://ntxbio.com?hsLang=en)

- [Technologies](https://ntxbio.com/technologies)
  
  Show submenu for Technologies 
  
    - [Overview](https://ntxbio.com/technologies)
    - [NTxscribe FLEX](https://ntxbio.com/ntxscribe)
    - [DNA Calculator](https://ntxbio.com/dna-template-calculator)
- [Who We Are](https://ntxbio.com/who-we-are)
- [News](https://ntxbio.com/news)
- [Careers](https://ntxbio.com/careers)
- White Papers
  
  Show submenu for White Papers 
  
    - [NTxscribe® Whitepaper](https://ntxbio.com/ntxscribe-whitepaper)

Open main navigation

Close main navigation

- [Technologies](https://ntxbio.com/technologies)
  
  Show submenu for Technologies 
  
    - [Overview](https://ntxbio.com/technologies)
    - [NTxscribe FLEX](https://ntxbio.com/ntxscribe)
    - [DNA Calculator](https://ntxbio.com/dna-template-calculator)
- [Who We Are](https://ntxbio.com/who-we-are)
- [News](https://ntxbio.com/news)
- [Careers](https://ntxbio.com/careers)
- White Papers
  
  Show submenu for White Papers 
  
    - [NTxscribe® Whitepaper](https://ntxbio.com/ntxscribe-whitepaper)
- [Contact us](https://ntxbio.com/contact-us)

[Contact us](https://ntxbio.com/contact-us?hsLang=en)

# Faster, Simpler RNA Manufacturing

## Produce RNA Where You Need It, in Your Lab.

NTx was founded to make biomanufacturing faster, simpler, and more accessible. Conventional RNA production relies on slow, complex, centralized batch processes that require large facilities, long lead times, and repeated process development. We built NTx to remove those barriers.

Our proprietary platform uses cell-free synthetic biology in a continuous-flow system, giving researchers and drug developers direct control over their own RNA production. Teams can produce a broad range of IVT-generated RNA constructs at the bench in hours, scale linearly from milligram to gram quantities, and carry the same process from discovery into clinical manufacturing.

##### **NTx Bio builds automated, continuous-flow systems for RNA manufacturing. Our NTxscribe® platform lets scientists produce high-quality RNA on demand at their own bench, with consistent output, a closed single-use workflow, and linear scalability from research through the clinic.**

###### **SUSTAINABLE**

Our biosynthesis technology is completely defined and is independent of cell lines

###### **CONSISTENT**

Our results are reproducible with limited artifacts

###### **SCALABLE**

Our biomanufacturing processes can be easily scaled to meet fluctuating supply needs

###### **BIOSYNTHETIC**

Our platforms are built for cell-free mRNA production

###### **EFFICIENT**

Rapid, high-quality, and low-cost production to accelerate lead optimization, pre-clinical testing and IND filings

### Executive Team

![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-08-2025-06-04-21-0308-PM.png?width=523&height=525&name=image-png-Mar-08-2025-06-04-21-0308-PM.png)

**Joan Haab**

Chief Executive Officer

**![SE](https://ntxbio.com/hs-fs/hubfs/SE.png?width=1654&height=1654&name=SE.png)**

**Steven Evans, PhD**

Chief Scientific Officer & Senior Vice President R&D

 

**![MR v2](https://ntxbio.com/hs-fs/hubfs/MR%20v2.png?width=347&height=371&name=MR%20v2.png)**

**Marcel Roche**

Chief Financial Officer

![MP v2](https://ntxbio.com/hs-fs/hubfs/MP%20v2.png?width=350&height=402&name=MP%20v2.png)

**Matthew Phillips**

Senior Vice President, Business Development

### Board of Directors

![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-08-2025-06-04-21-0308-PM.png?width=523&height=525&name=image-png-Mar-08-2025-06-04-21-0308-PM.png)

**Joan Haab**

Chief Executive Officer

[![DS updated](https://ntxbio.com/hs-fs/hubfs/DS%20updated.png?width=1654&height=1654&name=DS%20updated.png)](https://21945425.hs-sites.com/david-seldin?hsLang=en)

[**David Seldin**](https://ntxbio.com/david-seldin?hsLang=en)

Managing Partner, Anzu Partners

[![TN](https://ntxbio.com/hs-fs/hubfs/TN.png?width=1654&height=1654&name=TN.png)](https://21945425.hs-sites.com/thomas-nickoloff?hsLang=en)[**Thomas Nickoloff**](https://ntxbio.com/thomas-nickoloff?hsLang=en)

Managing Principal, Camino Real Capital Partners

**[![EL](https://ntxbio.com/hs-fs/hubfs/EL.png?width=1654&height=1654&name=EL.png)](https://21945425.hs-sites.com/edward-liddy?hsLang=en)**[**Edward Liddy**](https://ntxbio.com/edward-liddy?hsLang=en)

Former Chairman & CEO, Allstate Corporation

<https://21945425.hs-sites.com/david-seldin?hsLang=en>![](https://ntxbio.com/hs-fs/hubfs/image-png-Aug-07-2025-12-12-33-8294-AM.png?width=643&height=694&name=image-png-Aug-07-2025-12-12-33-8294-AM.png)

**Dave Johnson**<https://ntxbio.com/david-seldin?hsLang=en>

Board Member

[![TN](https://ntxbio.com/hs-fs/hubfs/TN.png?width=1654&height=1654&name=TN.png)](https://21945425.hs-sites.com/thomas-nickoloff?hsLang=en)[**Thomas Nickoloff**](https://ntxbio.com/thomas-nickoloff?hsLang=en)

Managing Principal, Camino Real Capital Partners

### Scientific Advisory Board

![](https://ntxbio.com/hs-fs/hubfs/image-png-3.png?width=400&height=421&name=image-png-3.png)

[**William Oh, MD**](https://ntxbio.com/william-oh?hsLang=en)

Scientific Advisory Board, Chair 

Yale School of Medicine 

![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-11-2025-08-08-57-7488-PM.png?width=411&height=448&name=image-png-Mar-11-2025-08-08-57-7488-PM.png)

<https://21945425.hs-sites.com/edward-liddy?hsLang=en>[**John P. Cooke, MD, Ph.D**](https://ntxbio.com/john-cooke?hsLang=en)

Houston Methodist Research Institute

<https://21945425.hs-sites.com/thomas-nickoloff?hsLang=en>

**![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-10-2025-04-57-48-8630-PM.png?width=407&height=426&name=image-png-Mar-10-2025-04-57-48-8630-PM.png)**

[**Yi Lin MD, Ph.D.**](https://ntxbio.com/yi-lin?hsLang=en)

Mayo Clinic

**![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-10-2025-05-06-11-8633-PM.png?width=406&height=451&name=image-png-Mar-10-2025-05-06-11-8633-PM.png)**

[**Thomas Marron, MD, Ph.D.**](https://ntxbio.com/thomas-marron?hsLang=en)

Icahn School of Medicine at Mount Sinai

![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-08-2025-06-12-48-7629-PM.png?width=410&height=433&name=image-png-Mar-08-2025-06-12-48-7629-PM.png)

[**Giselle L. Saulnier Sholler, MD**](https://ntxbio.com/giselle-sholler?hsLang=en)

Penn State Health /

Beat Childhood Cancer Research Consortium

![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-10-2025-05-16-21-4885-PM.png?width=398&height=432&name=image-png-Mar-10-2025-05-16-21-4885-PM.png)[**Elias Sayour, MD, Ph.D.**](https://ntxbio.com/elias-sayour?hsLang=en)

University of Florida

<https://21945425.hs-sites.com/thomas-nickoloff?hsLang=en>

![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-10-2025-05-24-58-3072-PM.png?width=409&height=425&name=image-png-Mar-10-2025-05-24-58-3072-PM.png)[**Padmanee Sharma, MD, Ph.D.**](https://ntxbio.com/padmanee-sharma?hsLang=en)

MD Anderson Cancer Center

![](https://ntxbio.com/hs-fs/hubfs/image-png-Mar-10-2025-05-34-49-5810-PM.png?width=404&height=425&name=image-png-Mar-10-2025-05-34-49-5810-PM.png)[**Catherine J. Wu, MD**](https://ntxbio.com/catherine-wu?hsLang=en)

Dana Farber Cancer Institute

![portrait\_circle\_transparent\_trimmed](https://ntxbio.com/hs-fs/hubfs/portrait_circle_transparent_trimmed.png?width=224&height=249&name=portrait_circle_transparent_trimmed.png)

**Jeff Coller, PhD**

Professor of RNA Biology and Therapeutics at Johns Hopkins University

#### Creating the fast lane for vital therapeutics.

[![](https://ntxbio.com/hs-fs/hubfs/Picture1.png?width=1224&height=332&name=Picture1.png)](https://www.ntxbio.com?hsLang=en)

NTx is enabling the future of medicine with cell-free biomanufacturing systems that drive breakthroughs in research, therapeutics, and personalized cancer vaccines. The company’s flagship NTxscribe platform brings industrial-grade RNA manufacturing to the benchtop, producing high-purity, high-integrity RNA with unmatched speed, efficiency, and scalability – all within a fully closed system. NTxscribe’s single-use RNA cartridges run on NTxbiomaterials, a proprietary line of reagents that are manufactured in the U.S. with fully domestic raw materials.

**PAGES** 

[Home](https://ntxbio.com/?hsLang=en)

[Technologies](https://21945425.hs-sites.com/technologies?hsLang=en)

[NTxscribe](https://21945425.hs-sites.com/ntxscribe?hsLang=en)®

[NTxpress](https://21945425.hs-sites.com/ntxpress?hsLang=en)®

[mRNA Services](https://21945425.hs-sites.com/mrna-services?hsLang=en)

[Cryo-EM Services](https://ntxbio.com/cryo-em-services-1?hsLang=en)

[Who We Are](https://21945425.hs-sites.com/who-we-are?hsLang=en)

**RESOURCES** 

[News](https://21945425.hs-sites.com/?hsLang=en)

[Careers](https://job-boards.greenhouse.io/ntx)

[Contact](https://21945425.hs-sites.com/contact-us?hsLang=en)

[DNA Template Calculator](https://ntxbio.com/dna-template-calculator?hsLang=en)

 

[Follow us on LinkedIn](https://www.linkedin.com/company/ntxbio)

Copyright ©  2016-2025 by Nature's Toolbox, Inc. | Nature's Toolbox, NTx, NTxBio, NTxpress, NTxscribe and NTxbiomaterials are registered trademarks of NTx